Pages that link to "Q41845349"

The following pages link to Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid (Q41845349):

Displaying 40 items.

• The Combination of Sulfamethoxazole, Trimethoprim, and Isoniazid or Rifampin Is Bactericidal and Prevents the Emergence of Drug Resistance in Mycobacterium tuberculosis (Q24633894) (← links)
• Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis (Q27003186) (← links)
• Characterization of the proline-utilization pathway in Mycobacterium tuberculosis through structural and functional studies (Q27689784) (← links)
• The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942 (Q27695697) (← links)
• Structure and inhibition of subunit I of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complex (Q27702561) (← links)
• High-throughput Screening and Sensitized Bacteria Identify an M. tuberculosis Dihydrofolate Reductase Inhibitor with Whole Cell Activity (Q28480878) (← links)
• A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strains (Q28482347) (← links)
• Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315 (Q28548282) (← links)
• Mycobacterium tuberculosis type II NADH-menaquinone oxidoreductase catalyzes electron transfer through a two-site ping-pong mechanism and has two quinone-binding sites (Q28660144) (← links)
• Comparative proteomics identifies the cell-associated lethality of M. tuberculosis RelBE-like toxin-antitoxin complexes (Q30549619) (← links)
• Overexpression, purification, crystallization and structure determination of AspB, a putative aspartate aminotransferase from Mycobacterium tuberculosis. (Q33872845) (← links)
• Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test (Q34278222) (← links)
• Regulated Expression Systems for Mycobacteria and Their Applications (Q34626585) (← links)
• Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex (Q35191465) (← links)
• Molecular cloning, overexpression, purification, crystallization and preliminary X-ray diffraction studies of histidinol phosphate aminotransferase (HisC2) from Mycobacterium tuberculosis (Q35660958) (← links)
• A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD adduct (Q35666603) (← links)
• Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria (Q36156072) (← links)
• The Chromosomal parDE2 Toxin-Antitoxin System of Mycobacterium tuberculosis H37Rv: Genetic and Functional Characterization (Q36999809) (← links)
• Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture (Q37466064) (← links)
• Is repositioning of drugs a viable alternative in the treatment of tuberculosis? (Q38053000) (← links)
• Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies (Q38258837) (← links)
• Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities. (Q38535724) (← links)
• Drug Resistance Mechanisms in Mycobacterium tuberculosis (Q38792870) (← links)
• The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis (Q38806183) (← links)
• Elongation of the Poly-γ-glutamate Tail of F420 Requires Both Domains of the F420:γ-Glutamyl Ligase (FbiB) of Mycobacterium tuberculosis (Q39483290) (← links)
• Protective vaccine efficacy of the complete form of PPE39 protein from Mycobacterium tuberculosis Beijing/K strain in mice (Q40064027) (← links)
• Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase (Q41880714) (← links)
• φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples. (Q41984560) (← links)
• Role of the Dihydrofolate Reductase DfrA (Rv2763c) in Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) Resistance in Mycobacterium tuberculosis (Q42376148) (← links)
• Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death (Q46524797) (← links)
• PdxH proteins of mycobacteria are typical members of the classical pyridoxine/pyridoxamine 5'-phosphate oxidase family (Q46603328) (← links)
• Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains. (Q55091455) (← links)
• Structural and functional determination of homologs of the Mycobacterium tuberculosis N-acetylglucosamine-6-phosphate deacetylase (NagA). (Q55501913) (← links)
• A GFP-strategy for efficient recombinant protein overexpression and purification in (Q57491193) (← links)
• A revised biosynthetic pathway for the cofactor F in prokaryotes (Q64073561) (← links)
• Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017 (Q64076245) (← links)
• Current possibilities and unresolved issues of drug target validation inMycobacterium tuberculosis (Q84248054) (← links)
• Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogen Mycobacterium tuberculosis (Q89581361) (← links)
• Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy (Q91304732) (← links)
• Utility of OhrR-Ohr system for the expression of recombinant proteins in mycobacteria and for the delivery of M. tuberculosis antigens to the phagosomal compartment (Q91947033) (← links)